Alveus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 02-05-2024
- Paid Up Capital ₹ 1.41 M
as on 02-05-2024
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Revenue 85.29%
(FY 2016)
- Profit -45.96%
(FY 2016)
- Ebitda -29.70%
(FY 2016)
- Net Worth 144.34%
(FY 2016)
- Total Assets 14.72%
(FY 2016)
About Alveus Pharmaceuticals
- CIN/LLPIN
U24232TG2009PTC065531
- Company No.
065531
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 2009
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Alveus Pharmaceuticals Private Limited offer?
Alveus Pharmaceuticals Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Chemical Intermediates.
Who are the key members and board of directors at Alveus Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasa Vankayalapati  | Whole-Time Director | 20-Dec-2010 | Current |
| Komala Vankayalapati | Director | 05-Jan-2022 | Current |
Financial Performance of Alveus Pharmaceuticals.
Alveus Pharmaceuticals Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 85.29% increase. The company also saw a substantial fall in profitability, with a 45.96% decrease in profit. The company's net worth Soared by an impressive increase of 144.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alveus Pharmaceuticals?
In 2017, Alveus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Arrien-Rajendra Spinning Mills Private LimitedActive 13 years 6 monthsSrinivasa Vankayalapati and Komala Vankayalapati are mutual person
- New Line Medicines Private LimitedActive 8 years 9 months
Srinivasa Vankayalapati and Komala Vankayalapati are mutual person
- Unitygrowth Investments Private LimitedActive 3 years 27 days
Srinivasa Vankayalapati and Komala Vankayalapati are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Alveus Pharmaceuticals?
Unlock and access historical data on people associated with Alveus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alveus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alveus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
